Evidence map›Paper›PMID 40968638›Full record

ArticleBiochemistry2025

Structure-Activity Relationship of an All-α-helical Prenyltransferase Reveals the Mechanism of Indole Prenylation.

Takumi Oshiro, Shuta Uehara, Arisa Suto, Yoshikazu Tanaka, Takuya Ito, Yoshio Kodera, Takashi Matsui

Abstract read
In one paragraph

Article in Biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Takumi OshiroDepartment of Physics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0373, Japan.ORCID 0009-0003-7183-1477
Shuta UeharaDepartment of Physics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0373, Japan.
Arisa SutoDepartment of Physics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0373, Japan.
Yoshikazu TanakaGraduate School of Life Science, Tohoku University, Sendai, Miyagi 980-8577, Japan.
Takuya ItoFaculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Osaka 585-8540, Japan.
Yoshio KoderaDepartment of Physics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0373, Japan.
Takashi MatsuiDepartment of Physics, School of Science, Kitasato University, Sagamihara, Kanagawa 252-0373, Japan.ORCID 0000-0002-4496-2389

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes are involved in the biosynthesis of a variety of secondary metabolites found in nature. The catalytic mechanism is regulated by the three-dimensional structure of the enzyme, particularly at the catalytic site, resulting in the synthesis of natural products with complex conformations derived from a regioselective, chemoselective, or stereoselective preference of the enzyme reaction. Prenyltransferase, which belongs to the prenylsynthase superfamily, catalyzes the condensation of isoprene to an aromatic compound, consequently producing a terpenoid scaffold structure. Prenyltransferase thus plays an important role in expanding the chemical diversity of the terpenoids. Although the three-dimensional structures of prenylsynthases categorized in the same superfamily have been resolved, the catalytic mechanism of prenyltransferase has been veiled. In this study, we determined the X-ray crystal structure of a novel prenyltransferase, Ord1, which is derived from

Indexed as

Bacterial ProteinsDimethylallyltranstransferaseIndolesStreptomycesCatalytic DomainCrystallography, X-RayModels, MolecularPrenylationProtein Conformation, alpha-HelicalStructure-Activity RelationshipSubstrate SpecificityBacterial ProteinsDimethylallyltranstransferaseindoleIndoles

Identifiers

PMID40968638
PMCPMC12510300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.